32 citations as recorded by crossref.

1. Antibiotic Therapy for Prosthetic Joint Infections: An Overview B. Le Vavasseur & V. Zeller 10.3390/antibiotics11040486
2. Urine Aluminum Concentration as a Possible Implant Biomarker of Pseudomonas aeruginosa Infection Using a Fluorine- and Phosphorus-Doped Ti-6Al-4V Alloy with Osseointegration Capacity J. Aguilera-Correa et al. 10.1021/acsomega.9b00898
3. Periprosthetic Joint Infection R. Miller et al. 10.2106/JBJS.RVW.19.00224
4. Novel Aminoglycoside-Tolerant Phoenix Colony Variants of Pseudomonas aeruginosa D. Sindeldecker et al. 10.1128/AAC.00623-20
5. Outcomes After Pseudomonas Prosthetic Joint Infections B. Kim et al. 10.5435/JAAOS-D-23-00704
6. Application of Phage Therapy in a Case of a Chronic Hip-Prosthetic Joint Infection due toPseudomonas aeruginosa: An Italian Real-Life Experience andIn VitroAnalysis N. Cesta et al. 10.1093/ofid/ofad051
7. Establishment of a Novel Rat Model of Gram-Negative Periprosthetic Joint Infection Using Cementless Hip Hemiarthroplasty M. Ibrahim et al. 10.2106/JBJS.22.00094
8. Outcomes of the Subsequent Periprosthetic Joint Infection Revisions after a Failed Debridement, Antibiotics and Implant Retention: A Multicentric Study of 197 Patients Á. Auñón et al. 10.1089/sur.2024.047
9. Antibacterial Activity in Iodine-coated Implants Under Conditions of Iodine Loss: Study in a Rat Model Plus In Vitro Analysis K. Ueoka et al. 10.1097/CORR.0000000000001753
10. Exploration of the Pharmacodynamics for Pseudomonas aeruginosa Biofilm Eradication by Tobramycin D. Sindeldecker et al. 10.1128/AAC.01371-21
11. Piperacillin Steady State Concentrations in Target Tissues Relevant for PJI Treatment—A Randomized Porcine Microdialysis Study Comparing Continuous Infusion with Intermittent Short-Term Infusion H. Rasmussen et al. 10.3390/antibiotics12030577
12. Multidrug-resistant and extensively drug-resistant Gram-negative prosthetic joint infections: Role of surgery and impact of colistin administration A. Papadopoulos et al. 10.1016/j.ijantimicag.2018.10.018
13. Promising applications of D-amino acids in periprosthetic joint infection M. Caldwell et al. 10.1038/s41413-023-00254-z
14. Distinct bacterial population dynamics and disease dissemination after biofilm dispersal and disassembly Y. Ma et al. 10.1038/s41396-023-01446-5
15. Lactobacillus cell‐free supernatant as a novel bioagent and biosurfactant against Pseudomonas aeruginosa in the prevention and treatment of orthopedic implant infection A. Jeyanathan et al. 10.1002/jbm.b.34821
16. Synergistic Activity of Fosfomycin, Ciprofloxacin, and Gentamicin Against Escherichia coli and Pseudomonas aeruginosa Biofilms L. Wang et al. 10.3389/fmicb.2019.02522
17. Genomic and transcriptomic profiling of phoenix colonies D. Sindeldecker et al. 10.1038/s41598-022-18059-1
18. Pseudomonas aeruginosa prosthetic joint-infection outcomes: Prospective, observational study on 43 patients H. Prié et al. 10.3389/fmed.2022.1039596
19. Anti-Pseudomonas aeruginosa Vaccines and Therapies: An Assessment of Clinical Trials M. Elmassry et al. 10.3390/microorganisms11040916
20. Multifunctionality of Nanosized Calcium Apatite Dual-Doped with Li+/Eu3+ Ions Related to Cell Culture Studies and Cytotoxicity Evaluation In Vitro P. Sobierajska et al. 10.3390/biom11091388
21. Multi-drug delivery system based on lipid membrane mimetic coated nano-hydroxyapatite formulations D. Placente et al. 10.1016/j.ijpharm.2018.07.036
22. Benefits and Adverse Events Associated With Extended Antibiotic Use in Total Knee Arthroplasty Periprosthetic Joint Infection N. Shah et al. 10.1093/cid/ciz261
23. Dual-route levofloxacin delivery following revision surgery: a synergistic intravenous/intra-articular strategy for enhanced bactericidal effect against prosthetic Pseudomonas aeruginosa infections M. Li et al. 10.1097/JS9.0000000000002712
24. Pseudomonas aeruginosa Implant-Associated Bone and Joint Infections: Experience in a Regional Reference Center in France M. Cerioli et al. 10.3389/fmed.2020.513242
25. The Use of Antibiotics in Periprosthetic Joint Infection 青. 杨 10.12677/ACM.2023.1351161
26. Clinical Outcome of Patients with Acute Periprosthetic Joint Infections Caused by Pseudomonas aeruginosa Compared to Other Gram-Negative Bacilli W. Liu et al. 10.3390/microorganisms13040904
27. Many Common Pathogens are Present in the Operative Room Air During Surgery E. Chisari et al. 10.1016/j.arth.2022.07.007
28. Microbiological profiles in periprosthetic joint infections after total knee arthroplasty: a comparative analysis of diabetic and non-diabetic patients M. Ergin et al. 10.1007/s00264-024-06275-5
29. A Successfully Treated Patient with Prosthetic Joint Infection Caused by <i>Pseudomonas aeruginosa </i>Diagnosed from PCR of Periprosthetic Joint Fluid K. FURUKAWA et al. 10.11150/kansenshogakuzasshi.94.338
30. Mouse model of Gram-negative prosthetic joint infection reveals therapeutic targets J. Thompson et al. 10.1172/jci.insight.121737
31. The many antibiotic resistance and tolerance strategies of Pseudomonas aeruginosa D. Sindeldecker & P. Stoodley 10.1016/j.bioflm.2021.100056
32. Predictive Antibiotic Susceptibility Testing by Next-Generation Sequencing for Periprosthetic Joint Infections: Potential and Limitations L. Lüftinger et al. 10.3390/biomedicines9080910